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Abstract
Despite an increasing pre-exposure prophylaxis (PrEP) use among populations at highest risk of 
HIV acquisition, comprehensive and easy access to PrEP is limited among racial/ethnic minorities 
and lowincome populations. The present study analyzed the geographic distribution of PrEP 
providers and the relationship between their location, neighborhood characteristics, and HIV 
incidence using spatial analytic methods. PrEP provider density, socio-demographics, healthcare 
availability, and HIV incidence data were collected by ZIP-code tabulation area in New York City 
(NYC). Neighborhood sociodemographic measures of race/ethnicity, income, insurance coverage, 
or same-sex couple household, were not associated with PrEP provider density, after adjusting for 
spatial autocorrelation, and PrEP providers were located in high HIV incidence neighborhoods 
(P<0.01). These findings validate the need for ongoing policy interventions (e.g. public health 
detailing) vis-à-vis PrEP provider locations in NYC and inform the design of future PrEP 
implementation strategies, such as public health campaigns and navigation assistance for low-cost 
insurance.
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Introduction
Despite a recent overall decrease in HIV incidence in the United States (U.S.), new HIV 
infections remain high among certain populations, including racial and ethnic minorities and 
low-income populations [1–3]. While black and Hispanics account for 12.3% and 17.6% of 
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the U.S. population, respectively, they comprise 44% and 26% of all HIV diagnoses in 2016 
[1]. The disproportionate burden of HIV among minorities is predominantly driven by 
marked social disparities and other behavioral factors, and some evidence suggests that 
racial/ethnic segregation may play an important role in this HIV epidemic [4]. Many studies 
have identified disparities in health outcomes, health behaviors, and access to healthcare 
services in segregated neighborhoods [5, 6]. Sexually transmitted infections, of which HIV 
is one, have also been found to be associated with such residential segregation [7, 8], but 
only a handful of studies have investigated local segregation of HIV care/prevention 
resources [9].
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy [10–13]; however, 
access to PrEP is often limited among racial/ethnic minorities and low-income populations 
[14–19]. Studies have reported that PrEP acceptability among at-risk black and Hispanic 
populations, such as gay, bisexual, other men who have sex with men (MSM), and 
transgender women, is similarly high to other populations [20], yet rates of PrEP uptake 
among such racial, sexual, and gender minority groups have remained much lower relative to 
their white counterparts [21, 22]. Studies have proposed possible explanations for PrEP 
access disparities, including healthcare availability, income, education, and barriers 
associated with geography [17–19, 23].
The present study describes geographic variation in access to PrEP providers in New York 
City (NYC), and examines the relationship between geographic access, neighborhood socio-
demographics, healthcare provider availability, and HIV incidence, using spatial analytic 
methods for spatial autocorrelation. Spatial autocorrelation refers to interdependencies 
among observations in variables. The presence of spatial autocorrelation violates the major 
assumption of independence of observations and can lead to biased estimates of parameters 
[24–27]. In this study, we hypothesized that neighborhoods with certain socio-demographic 
profiles (e.g., higher percent Black, Hispanic, or poverty) and a high HIV incidence would 
have limited access to PrEP providers in NYC.
Methods
Data
The present study used the PrEP Locator Database provided by the Centers for Disease 
Control and Prevention National Prevention Information Network (CDC NPIN) [28]. The 
PrEP Locator is a national database of PrEP-prescribing clinics, hospitals, and organizations, 
providing a unified and vetted source of PrEP providers across the U.S. The data collection 
process included web searches, referrals, and outreach to state health departments, and the 
dataset was consistently reviewed by an advisory board and staff of CDC NPIN. Details of 
the database’s methodology for data collection and maintenance have been described 
elsewhere [29]. We chose NYC as our study site, as the largest urbanized city in the U.S. 
with high concentrations multi-racial/ethnic populations. Also, NYC has one of highest HIV 
incidence and prevalence in the U.S. [1]. By October 2018, there were 154 registered PrEP 
providers in NYC. Five-year cumulative new HIV diagnosis case data were obtained by ZIP 
code tabulated area (ZCTA)-level from the NYC Department of Health and Mental Hygiene 
(NYC DOHMH) [30] via AIDSVu [31]. The new diagnosis cases represent people newly 
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diagnosed HIV infection regardless of the stage of disease (stage 0, 1, 2, 3 [AIDS], or 
unknown) reported to the NYC DOHMH from January 1, 2012 to December 31, 2016. The 
HIV incidence was calculated as an incidence rate per person-year. Socio-demographic data 
were retrieved from the 2013–2017 American Community Survey by ZCTA level, including: 
the percentage of Hispanic, non-Hispanic black, Asian, white, the percentage of people with 
annual incomes below the federal poverty level, the percentage of people without health 
insurance, and the percentage of same-sex couple household as a proxy of gay population. In 
addition, the availability of general healthcare providers was calculated as density per 
100,000 population. Data for public and private healthcare providers were accessed through 
the Health Facility General Information provided by New York State Department of Health, 
and the number of hospitals, diagnostic and treatment centers, mobile diagnostic and 
treatment centers, and their extensions were divided by population by ZCTA. There were a 
total 211 ZCTAs in NYC.
The PrEP providers’ addresses were geocoded using a common geocoding method, ArcGIS 
(ESRI, Redlands, CA, USA) [32]. The number of point locations of all PrEP providers in 
NYC was counted by ZCTA level, and the number of PrEP providers per population of 
100,000 were calculated as a marker of PrEP provider density. A total of 47 ZCTA with a 
small number of new HIV diagnoses (less than 5) and/or population size (less than 500) had 
missing incidence data due to confidentiality issue thus excluded from the analysis. One 
isolated ZCTA was also excluded due to a limitation of spatial autocorrelation analysis for 
zero neighbors. A total of 163 ZCTAs in NYC with valid HIV incidence, socio-
demographics, healthcare availability, and PrEP provider density were included in the final 
analyses. Spatial data processing were done in ArcGIS 10.6 (ESRI, Redlands, CA, USA).
Statistical Analysis
We examined spatial autocorrelation of all socio-demographics, healthcare provider 
availability, HIV incidence, and PrEP provider location variables using the Global Moran’s 
I. Previous health research assessing neighborhood characteristics and built environments 
applied similar spatial approach [33–36]. In this study, we employed a row-standardized 
binary contiguity spatial weight matrix based on first-order Queen criteria, which is 
commonly used with areal data [37]. The Queen’s contiguity spatial weights matrix defines 
neighbors as ZCTAs that share a common boundary or a corner. A pseudo P-value for the 
Moran’s I was calculated using a Monte Carlo simulation of 999 random trials. Moran’s I 
values range between −1 to 1, and a value near 1 suggests clustered similarities and positive 
spatial autocorrelation. We also tested Spearman correlations adjusting for the spatial 
autocorrelation between study variables and PrEP provider density. Non-spatial bivariate and 
multivariate models were specified with various Lagrange Multiplier (LM) tests for spatial 
autocorrelation on the residuals of these fitted non-spatial ordinary least squares (OLS) 
models. The LM tests are diagnostics to assess spatial dependence based on Lagrange 
Multiplier principle, and those can be used when Moran’s I is statistically significant [24, 
38, 39]. Finally, as appropriate, spatial error models (SEM) or spatial lag models (SLM) 
were developed to account for spatial autocorrelation [24–27], and we evaluated the 
goodness-of-fit for each model using Akaike Information Criterion (AIC) [40, 41]. We used 
R statistical software 3.5.1 (R Core Team, 2018).
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Results
Descriptive and Spatial Statistics
The mean ZCTA-level PrEP provider density was 1.89 per 100,000 (standard deviation (SD) 
=3.13, range=0 to 16.7) for the analytic sample of 176 ZCTAs (Table 1). Mean HIV 
incidence rate was 0.007 per person-year (7/1,000-person year) (SD=0.005, range=0.0 to 
0.03). A large range exists for the neighborhood socio-demographics, especially for ZCTA 
percent non-Hispanic black and white (Table 1).
The Global Moran’s I for PrEP provider density was 0.49 (P<0.01) (Table 1). We also 
identified positive significant global spatial autocorrelation in all of the neighborhood 
characteristics and HIV incidence rate (Global Moran’s I range from 0.51 to 0.75, all 
P<0.01). Figure 1 shows maps of the spatial distribution of PrEP provider density, key 
neighborhood characteristics, and HIV incidence rate by ZCTA level.
Correlation between Neighborhood Socio-demographics, Healthcare Availability, HIV 
Incidence and PrEP Provider Density
Table 2 shows the traditional Spearman correlation and Spearman correlation accounting for 
spatial autocorrelation. From conventional correlation analyses, percentage Asian (rs =−0.21, 
P<0.01), below poverty (rs =0.22, P<0.01), same-sex couple household (rs =0.44, P<0.01), 
health care provider density (rs =0.53, P<0.01), and HIV incidence (rs =0.44, P<0.01) were 
significantly correlated with PrEP provider density. The spatially adjusted analyses showed 
that only percentage same-sex couple household (rs =0.44, P<0.01), healthcare density (rs 
=0.53, P<0.01) and HIV incidence (rs =0.44, P<0.01) were correlated with PrEP density of 
ZCTAs. Only percentage of non-Hispanic Asian variable showed a negative correlation 
between PrEP provide density from conventional correlation test (rs =−0.21, P<0.01). The 
magnitudes of correlation were largest for healthcare provider density (rs =0.53), and HIV 
incidence as well as percentage of same-sex couple household (both rs=0.44), suggesting 
those three variables were powerful predictors of PrEP provider density.
Spatial Regression Analyses of the Relationship between Neighborhood Socio-
demographics, Healthcare Availability, HIV Incidence, and PrEP Provider Density
We found that HIV incidence was positively associated with PrEP provider density in all 
non-spatial and spatially adjusted bivariate models (Table 3). The percent of the population 
that was non-Hispanic Asian was negatively correlated with PrEP provider density from the 
non-spatial bivariate model, but from multivariate models the association did not attain 
statistical significance (Table 3). The Moran’s I for the non-spatial multivariate OLS 
regression residual was positive and significant (Moran’s I =0.07, P<0.05) (Table 3). The 
LM test was significant for spatial lag model (LM error P=0.19, LM lag P<0.01), confirming 
the need for SLM, and since the p-value of LM lag was smaller, robust SLM would be 
regarded as better model fitting [42]. Table 3 also shows the result of multivariate models 
including the SLM. In the SLM, the coefficients of all socio-demographics variables were 
not statistically significant, and only healthcare density (b=0.13, P<0.01), and HIV incidence 
(b=211.3, P<0.01) remained strong positive predictors of PrEP provider density. For 
example, one person-year increase in HIV incidence is associated with 211 increase in PrEP 
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provider density (/100,000) in a ZCTA in NYC. As examined from LM tests, the SLM had 
smaller AIC than SEM, suggesting a better model fit (data now shown).
Discussion
Our findings suggest that PrEP providers in NYC are effectively distributed in high HIV 
incidence neighborhoods. Contrary to our hypothesis, neighborhoods with a high percentage 
of black, Hispanic, and a population below federal poverty level, were not associated with 
lower levels of PrEP provider density. Although percentages of Asian and uninsured 
population were negatively associated with PrEP density from our bivariate model, the 
associations did not retain significance in our spatially adjusted multivariate model. Previous 
individual-level studies have identified ease of physical access to PrEP providers as a PrEP 
access barrier [43, 44], but in NYC, we found a relatively high concentration of PrEP 
providers in neighborhoods with a population groups who may seek PrEP subscriptions. 
Public efforts including stakeholder engagement and public health detailing to increase 
utilization of PrEP prescription in high-risk and/or vulnerable areas could play important 
roles in this balanced PrEP location. From 2014, NYC DOHMH began marketing PrEP 
directly to clinicians in a project funded jointly by the CDC and the municipality, as public 
health detailing to address PrEP disparities. In fact, the NYC DOHMH had a deliberate 
strategy to increase PrEP providers in high prevalence areas and prioritized medical 
practices that diagnosed HIV among people of color based on surveillance data [45].
These findings can guide future PrEP implementation strategies to target populations 
disproportionately impacted by the HIV epidemic, including blacks and Hispanics. In 
addition to geographical access to PrEP providers, studies have proposed other potential 
barriers and facilitators to PrEP use, including limited PrEP awareness, lack of culturally-
specific marketing and information, and increased concerns about the effectiveness of PrEP, 
long- and short-term side-effects, adherence to PrEP, and cost of PrEP [17, 18, 44, 46–50]. 
In NYC, public health campaigns designed to enhance PrEP awareness and knowledge, and 
to provide information about availability and accessibility of PrEP provider locations, as 
well as assistance for low-cost health insurance and tailored coordination of healthcare 
services, could likely further increase the PrEP uptake among at-risk populations such as 
MSM of color and transgender women.
This study has several limitations. First, the study sample was 163 ZCTAs in NYC with a 
relatively high density of PrEP providers and easy access to public transportation. Thus, the 
results may not be generalizable to other cities or rural areas. Second, there are inherent 
limitations to an ecological study design, including ecological fallacy. Individual-level 
barriers and facilitators to PrEP use were not accounted for in this study, thus it is possible 
that areas with high PrEP provider density may not be associated with PrEP uptake and 
adherence. Third, neighborhood was designed using ZCTA, which is an arbitrary boundary 
with heterogeneity [5, 51]. Thus, there might be a potential modifiable areal unit problem 
(MAUP), that the study results may have differed by the neighborhood definition used [52, 
53]. However, the smallest geographical level of HIV incidence data was ZCTA, and the 
ZCTA level was frequently used due to available health information [5, 54]. Fourth, the 
healthcare provider data did not specify private and public clinics, so we were not able to 
Kim et al. Page 5
AIDS Behav. Author manuscript; available in PMC 2020 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
include proportion of public healthcare facilities in the analysis, which may be relevant to 
the PrEP provider density. Lastly, there was a temporal mismatch between the datasets used. 
The HIV incidence data was cumulative number between 2012 and 2016, and the socio-
demographics were 5-year estimate between 2013 and 2017. The PrEP provider location 
data were retrieved as of October 2018.
Despite limitations, the findings suggest that there are effective policy interventions (e.g., 
NYC DOHMH’s public health detailing) vis-à-vis PrEP provider locations within 
neighborhoods with high HIV incidence in NYC, which may partly explain recent local 
decreases in HIV incidence [55]. However, while allocating resources to identified high HIV 
incidence neighborhoods is necessary, it may not be sufficient to effectively curtail the HIV 
epidemic. As the results indicate, PrEP provider density was not associated with a high 
percentage of black, Hispanic, low-income, or same-sex couple household neighborhoods. 
These neighborhoods, while having lower HIV incidence, at this time, may have a high 
prevalence of risk networks, particularly related to HIV-associated substance use and sexual 
behavior. Thus, these neighborhoods remain at disproportionate risk of HIV and may benefit 
from additional PrEP provider locations.
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Figure 1. Spatial Distribution of PrEP Provider, HIV Incidence Rate, Socio-demographics, and 
Healthcare Availability in New York City (ZCTA Level) *
* 47 ZCTAs were excluded from the map due to small a number of new HIV diagnose (less 
than 5) and/or population size (less than 500)
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Table 1.
Descriptive Statistics and Global Spatial Autocorrelation (N=163)
Mean (SD) Range Moran’s I P-value
PrEP Provider Density (/100,000) 1.89 (3.13) 0.0 – 16.7 0.49 0.001
Percent non-Hispanic Black 21.4 (24.3) 0.4 – 90.8 0.73 0.001
Percent Hispanic 27.6 (19.6) 5.6 – 74.3 0.75 0.001
Percent non-Hispanic Asian 14.1 (13.9) 0.0 – 72.7 0.67 0.001
Percent non-Hispanic White 33.7 (25.5) 0.6 – 84.3 0.64 0.001
Percent below Poverty 18.1 (9.8) 3.2 – 46.4 0.67 0.001
Percent Uninsured 9.2 (4.3) 0.8 – 26.3 0.51 0.001
Percent same-sex partner household 0.51 (0.65) 0.0 – 3.4 0.54 0.001
Healthcare Provider Density (/100,000) 10.0 (9.9) 0.0 – 56.8 0.21 0.001
HIV Incidence Rate (/person-year) 0.007 (0.005) 0.0 – 0.03 0.65 0.001
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Table 2.
Spearman Correlation between ZCTA Level Socio-Demographics/HIV Prevalence and PrEP Density (N=163)
rs Conventional P-value Spatially adjusted P-value
Percent non-Hispanic Black 0.12 0.12 0.29
Percent Hispanic 0.02 0.83 0.92
Percent non-Hispanic Asian −0.21 0.01 0.13
Percent non-Hispanic White 0.07 0.38 0.68
Percent below Poverty 0.22 0.01 0.13
Percent Uninsured −0.13 0.09 0.33
Percent same-sex partner household 0.44 0.00 0.01
Healthcare Provider Density (/100,000) 0.53 0.00 0.00
HIV Incidence Rate (/person-year) 0.44 0.00 0.00
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Table 3.
Model Estimations of the Relationship between ZCTA Level Socio-Demographics, Healthcare Availability, 
HIV Incidence Rate, and PrEP Density with Model Diagnostics for Spatial Autocorrelation and Goodness-of-
fit (N=163)
Non-Spatial OLS Spatial Lag Model
Coefficient (SE) P-value Coefficient (SE) P-value
Bivariate Estimation
Percent non-Hispanic Black −0.11 0.91 0.3 0.7
Percent Hispanic −0.28 0.83 −0.07 0.94
Percent non-Hispanic Asian −4.14 0.02 −1.64 0.24
Percent non-Hispanic White 1.66 0.08 0.32 0.68
Percent below Poverty 4.23 0.09 2.26 0.26
Percent Uninsured −15.1 0.01 −5.35 0.24
Percent same-sex partner household 210.0 0.00 126.07 0.00
Healthcare Provider Density 0.19 0.00 0.14 0.00
HIV Incidence Rate (/person-year) 320.0 0.00 206.54 0.00
Multivariate Estimation
Percent non-Hispanic Black −1.33 0.82 −0.72 0.89
Percent Hispanic −1.33 0.82 −0.95 0.86
Percent non-Hispanic Asian −1.65 0.79 −0.97 0.87
Percent non-Hispanic White −0.22 0.97 −0.26 0.96
Percent below Poverty −0.8 0.77 −1.55 0.54
Percent Uninsured −7.61 0.22 −4.56 0.44
Percent same-sex partner household 43.75 0.33 33.22 0.42
Healthcare Provider Density 0.15 0.00 0.13 0.00
HIV Incidence Rate (/person-year) 261.4 0.00 211.3 0.00
Multivariate Model Diagnostic
Global Moran’s I 0.07 0.02 - -
LM Spatial Error Model P-value 1.73 0.19 - -
LM Spatial Lag Model P-value 9.78 0.00 - -
Robust LM P-value - - 0.00
AIC 722 714
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